Ohio APRN Practice and Prescribing Laws
Contact Hours: 2
What's included?
Course Overview
This course offers a comprehensive overview of the steps and requirements for Advanced Practice Registered Nurses (APRNs) seeking licensure and prescriptive authority in Ohio, specifically those who did not complete their MSN course of study in Ohio. Learners will explore the critical processes involved, including application submission to the state Board of Nursing, credential evaluation, national certification verification, criminal background checks, DEA registration for prescribing controlled substances, completion of state-specific continuing education, and registration with prescription monitoring programs.
The course emphasizes understanding Ohio-specific regulations, maintaining accurate documentation, and staying informed about legal and ethical standards to ensure a smooth transition into a new practice environment and equips participants with practical knowledge and strategies to navigate licensure complexities and uphold high-quality care while complying with state laws.
Course Outline
- Introduction
- Overview of Advanced Practice Registered Nurses (APRNs) in Ohio
- Successful Completion of the Advanced Pharmacology Course
- Licensure Requirements for Out-of-State APRNs
- Scope of Practice for APRNs in Ohio
- Overview of Ohio’s APRN Prescribing Laws
- Prescribing Controlled Substances
- Record-Keeping Requirements
- Compliance with the Prescription Monitoring Program
- Prescriptive Authority
- Collaborative Agreements and Independence
- Limitations and Extensions of Scope – OAC 4723-8-02
- Understanding Schedule II Controlled Substances
- Regulatory Requirements for Prescribing Schedule II Medications
- Prescription Writing Standards – OAC 4723-9-10
- Electronic Prescribing (e-Prescribing) Requirements
- Record-Keeping and Documentation
- Clinical Considerations in Schedule II Prescribing
- Best Practices for Prescribing Schedule II Medications
- Case Study: APRN’s Transition to Practice in Ohio
- Key Takeaways for APRNs Seeking Licensure in a New State
- Conclusion
Course Outcomes
After completing this course, the learner will rate a 4 out of 5 on the Likert Scale for their ability to:
- Identify and describe the recognized APRN designations in Ohio.
- Examine the scope of practice for APRNs in Ohio, with particular attention to prescribing authority.
- Interpret Ohio’s prescribing laws and regulations, integrating federal guidelines to ensure compliant practice.
- Differentiate Schedule II controlled substances by classification and apply appropriate prescribing protocols to manage associated risks.
- Implement evidence-based prescribing practices for Schedule II medications to promote patient safety and maintain adherence to legal standards.
Accreditations and Approvals
- American Nurses Credentialing Center (ANCC) (P0614)
- California Board of Registered Nursing (CEP 17418)
- Kentucky Board of Nursing (7-0090)
- Louisiana State Board of Nursing (58)
- Florida Board of Nursing (50-23983)
- Delaware Board of Nursing (DE-24-010127)
- Alabama Board of Nursing (#ABNP1577)
- Iowa Board of Nursing (#393)
- Kansas Board of Nursing (LT0340-0325)
Ohio Nurses Association (OBN-001-91)
Approved by the Board of Nursing in every state, you can complete your RN, LVN, and APRN CEUs with confidence.
Accreditation Statement
Nursing CE Central LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
It will take the average learner 120 minutes to complete and awards 2 contact hours of continuing education.
Written For
- Advanced Practice Registered Nurses (APRN)
Requirements for Completion
- Enrollment in the course by the learner
- Read and learn all course materials
- Complete the course evaluation
- Attest and testify learning of the course materials
Disclosure of Relevant Financial Relationships
Nursing CE Central nor any of the authors, planners, content experts, or any contributors have any relevant financial relationships with ineligible companies to disclose.
